Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes

OBJECTIVE: To assess the efficacy and tolerability of alogliptin plus pioglitazone for initial combination therapy in drug-naïve type 2 diabetic patients. RESEARCH DESIGN AND METHODS: This 26-week, double-blind, parallel-group study randomized 655 patients with inadequately controlled type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, Julio, Inzucchi, Silvio E., Seufert, Jochen, Fleck, Penny R., Wilson, Craig A., Mekki, Qais
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963503/
https://www.ncbi.nlm.nih.gov/pubmed/20724648
http://dx.doi.org/10.2337/dc10-0159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963503/
https://www.ncbi.nlm.nih.gov/pubmed/20724648
http://dx.doi.org/10.2337/dc10-0159

Ejemplares similares